A microRNA diagnostic biomarker for amyotrophic lateral sclerosis

Print
Related Pages
Pubs
Affiliates Sandra Anne Banack [1], Rachael A Dunlop [1], Paul Mehta [2], Hiroshi Mitsumoto [3], Stewart P Wood [1], Moon Han [2], Paul Alan Cox [1]

 

1. Brain Chemistry Labs, Jackson, WY 83001, USA
2. Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA 30033, USA
3. Eleanor and Lou Gehrig MND/ALS Research Center, Department of Neurology, Columbia University Medical Center, New York, NY 10032, USA
Journal Brain Communications
Summary This paper from Brain Chemistry Labs aims to propose a new blood test for amyotrophic lateral sclerosis (ALS). It discusses the challenges of diagnosing ALS and the need for better biomarkers. The authors propose an eight-microRNA signature test using extracellular vesicles in blood plasma. They found this test to be accurate in identifying ALS patients. This test could aid in earlier diagnosis and improve patient outcomes.
Link to paper Read the paper here!